Vectura Group Share Price (VEC)

148.90 +1.20 (+0.81%) delayed: 1:18AM BST
Bid price 148.70 Open price 147.30
Ask price 148.90 Prev close 148.90
High price 150.00 Spread 0.13%
Low price 146.20 Volume 2,938,618

Register now for FREE live Vectura Group share prices, Vectura Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Vectura Group Level 2 Data, indepth research tools and investor commentary for Vectura Group (VEC) and other London Stock Exchange equities.

Vectura Group Share Price Chart

Advanced Charts >>

Register now for FREE Vectura Group share price charts

Vectura Group Share Price Information

Name Vectura Group Epic VEC
Sector Pharmaceuticals & Biotechnology ISIN GB00B01D1K48
Activites Vectura Group plc develops inhaled therapies principally for the treatment of respiratory diseases. Vectura's main products target diseases such as asthma and chronic obstructive pulmonary disease (COPD), a growing market that is currently estimated to be worth in excess of $25bn. Vectura has seven products marketed by its partners and a portfolio of drugs in clinical and pre-clinical development, a number of which have been licensed to major pharmaceutical companies. Vectura has development collaborations and licence agreements with several pharmaceutical companies, including Novartis, Sandoz (the generics arm of Novartis), Baxter and GlaxoSmithKline (GSK). Vectura seeks to develop certain programmes itself where this will optimise value. Vectura's formulation and inhalation technologies are available to other pharmaceutical companies on an out-licensing basis where this complements Vectura's business strategy. Index FTSE 250

Vectura Group Key Numbers

Latest Share Price (p) 148.90 Net Gearing (%) -17.92
Market Capitalisation (£m) 606.35 Gross Gearing (%) 17.01
Shares in issue (m) 410.53 Debt Ratio 8.28
P/E Ratio 123.08 Debt-to-Equity Ratio 0.44
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.21
Dividend Yield (%) 0.00 Price to book value 2.56
Dividend cover (x) 0.00 ROCE (%) -0.73
Earning per share (p) 1.20 EPS Growth (%) 33.33
52 week high / low 200.00 / 140.60 DPS Growth (%) n/a

Vectura Group Director Deals

Dec.Date Type Director Pos No. of Shares
08/07/2016 EXR Andrew Derodra FD 344,267
08/07/2016 SEXR Andrew Derodra FD 263,364
20/06/2016 EXR Andrew Derodra FD 150,000
20/06/2016 SEXR Andrew Derodra FD 150,000
14/06/2016 EXR Andrew Derodra FD 279,774

More Vectura Group Director Deals >>

Vectura Group Company News

16:20 28/07/2016

Broker Forecast - Numis issues a broker note on Vectura Group PLC

Numis today reaffirms its buy investment rating on Vectura Group PLC (LON:VEC) and set its price target at 246p. Story provided by

17:19 27/07/2016

Vectura initiates legal proceedings against GSK

/* */ RNS Number : 4443F Vectura Group plc 27 July 2016   Vectura Group plc   Vectura initiates legal proceedings against GSK relating to option-to-licence patent agreement and confirms 2016 revenue guidance   This announcement includes inside...

07:00 22/07/2016

Change of accounting reference date

/* */ RNS Number : 9274E Vectura Group plc 22 July 2016   Vectura Group plc Change of accounting reference date   Chippenham, UK - 22 July 2016:  Vectura Group plc (LSE: VEC) ("Vectura", "the Group"), an industry-leading inhaled airways disease...

More Vectura Group Company News >>

Register now for FREE Vectura Group company news

Vectura Group Share Price Discussions

more than 1 year ago


Powered by IST's

Register now for FREE Vectura Group share price discussions